A nomogram was constructed using Cox regression analysis to predict the survival probability of glioma patients at 1, 3 and 5 years based on MAP3K1 expression and clinicopathologic factors (Figure 2N). The gene discussed is MAP3K1; the disease is central nervous system cancer.